AG ILMER
Pancreatic Cancer Stem Cells
PD Dr. med. Matthias Ilmer
Oberarzt, Leitung Chirurgische Forschung
vgbbWazlgcslävipJvimtfaulhvfiuyziutmi
This working group tries to identify key mechanisms of cancer stem cell (CSC) pathway regulation with the help of which we aim to develop novel translational therapeutic concepts that will help to defeat pancreatic cancer in patients in the future.
Current projects:
- Sensitization for TRAIL-induced apoptosis in PDAC models (Project 1)
- Impact of NK1R Inhibition of cancer cells (Project 2)
- Modulation of metabolism impacts PDAC cell survival (Project 3)